- Home
- ANSC vs TRML Comparison
ANSC vs TRML Comparison
Compare ANSC & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANSC
- TRML
- Stock Information
- Founded
- ANSC 2021
- TRML 2021
- Country
- ANSC United States
- TRML United States
- Employees
- ANSC N/A
- TRML N/A
- Industry
- ANSC
- TRML Biotechnology: Pharmaceutical Preparations
- Sector
- ANSC
- TRML Health Care
- Exchange
- ANSC Nasdaq
- TRML Nasdaq
- Market Cap
- ANSC 448.3M
- TRML 419.1M
- IPO Year
- ANSC 2023
- TRML N/A
- Fundamental
- Price
- ANSC $10.42
- TRML $25.36
- Analyst Decision
- ANSC
- TRML Strong Buy
- Analyst Count
- ANSC 0
- TRML 3
- Target Price
- ANSC N/A
- TRML $65.00
- AVG Volume (30 Days)
- ANSC 225.9K
- TRML 166.5K
- Earning Date
- ANSC 01-01-0001
- TRML 11-07-2024
- Dividend Yield
- ANSC N/A
- TRML N/A
- EPS Growth
- ANSC N/A
- TRML N/A
- EPS
- ANSC N/A
- TRML N/A
- Revenue
- ANSC N/A
- TRML N/A
- Revenue This Year
- ANSC N/A
- TRML N/A
- Revenue Next Year
- ANSC N/A
- TRML N/A
- P/E Ratio
- ANSC $54.96
- TRML N/A
- Revenue Growth
- ANSC N/A
- TRML N/A
- 52 Week Low
- ANSC $10.05
- TRML $12.12
- 52 Week High
- ANSC $10.43
- TRML $48.31
- Technical
- Relative Strength Index (RSI)
- ANSC 63.38
- TRML 44.45
- Support Level
- ANSC $10.38
- TRML $25.58
- Resistance Level
- ANSC $10.42
- TRML $27.51
- Average True Range (ATR)
- ANSC 0.02
- TRML 1.75
- MACD
- ANSC 0.00
- TRML -0.34
- Stochastic Oscillator
- ANSC 80.00
- TRML 5.72
About ANSC Agriculture & Natural Solutions Acquisition Corporation
Agriculture & Natural Solutions Acquisition Corp is a blank check company.
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.